ABSTRACT. Male infertility is a heterogeneous disorder, with various genetic and environmental factors that contribute to the impairment of spermatogenesis. Genetic causes are responsible for 60% of cases of idiopathic infertility. Polymorphisms of genes that encode detoxifying enzymes of phase II drug metabolism can modify their expression or function, affecting the biotransformation of toxic compounds to which the male reproductive system is exposed. GSTM1 and GSTT1 encode enzymes that are essential in the process of detoxification of endogenous and exogenous xenobiotics, facilitating their excretion. We examined GSTM1 and GSTT1 polymorphism in 233 men with idiopathic infertility seen at the Human Reproduction Service of the Federal University of Goiás from [2004][2005][2006]. Genotype GSTM1/T1 (null) was found in 30/105 normal individuals and in 64/128 abnormal individuals, indicating a significant association with idiopathic male infertility. The sperm alteration associated with greater GSTM1/T1 (null) frequency was decreased sperm count (oligozoospermy), which was more frequent in patients with GSTM1 (78.9%) as well as in those who had GSTT1 (73.7%), although the difference was not significant. Individuals polymorphic for genes GSTM1 and GSTT1 are susceptible to reduction in sperm quality and infertility, possibly because oligozoo- 
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INTRODUCTION
Infertility is a significant problem, affecting up to 15% of couples of reproductive age (Pasqualotto et al., 2004) . Approximately 30% of men seeking treatment for their infertility present no demonstrable etiology and their condition remains idiopathic (Pasqualotto and Pasqualotto, 2006) . It is a heterogeneous disorder, with several genetic and environmental factors contributing to impaired spermatogenesis (Aydemir et al., 2007) . Studies revealed a significant decline in human semen quality and quantity over the past decades, and the increasing occurrence of disorders of the male reproductive tract is yet unknown. Environmental factors have been suggested to be implicated in the conditions of poor sperm function and infertility (Nakata et al., 2004; Rubes et al., 2007) .
Xenobiotics constitute the majority of the environmental factors. They include naturally occurring compounds, drugs, environmental agents, and carcinogens. Adverse effects of xenobiotics are exerted via covalent interactions between intermediate metabolites and genetic components or proteins and their related metabolites (Nakata et al., 2004; Rubes et al., 2007) .
Glutathione S-transferases (GSTs) constitute a superfamily of ubiquitous, multifunctional enzymes, which play a key role in phase II cellular detoxification and bioactivation reactions and are generally considered to be ''antioxidant'' enzymes (Schuppe et al., 2000; Hemachand and Shaha, 2003; Huber et al., 2008) . These are widely expressed in mammalian tissues and have broad substrate specificity. GSTs are expressed in all living mammals and constitute more than 4% of the total soluble protein (Hatagima, 2002) . Based on similarity of the amino acid sequence, GSTs have been grouped into at least seven classes known as alpha (a), mi (m), pi (p), theta (q), zeta (z), sigma (s), and more recently discovered omega (W) (Coughlin and Hall, 2002) .
Numerous genetic polymorphisms have been reported for GST enzymes (Hatagima, 2002; Joseph et al., 2006) resulting in a lack of functional protein or causing either increased or decreased metabolic activity (Rubes et al., 2007; Taspinar et al., 2008) . Genes encoding the GST Mu-1 and Theta-1 (GSTM1 and GSTT1, respectively) isoforms are polymorphic (Chen et al., 2002; Nakata et al., 2004) . Homozygotes for the mutated inactive alleles of each gene are devoid of any specific enzymatic activity of GSTM1 or T1 (null genotypes) (Schuppe et al., 2000) .
Several epidemiological studies have reported that the GSTM1 and GSTT1 null genotypes are correlated with an increased susceptibility to diseases associated with oxidative stress and have proposed that GSTM1 and GSTT1 could be a critical isozyme in the detoxification of oxidative stress (Alvarez and Moraes, 2006; Aydemir et al., 2007) . Although it has been shown that sperm surface GSTs are enzymatically active, the precise mechanism by which they protect spermatozoa is not clear (Chen et al., 2002; Aydemir et al., 2007) .
The enzymatic deficiency of isoforms of GSTs has been correlated with increased risk to develop certain diseases associated with oxidative damage, such that an association between the genotypes GSTM1 and GSTT1 and the idiopathic infertility is possible. Because of the role of GSTs in inactivating endogenous end products formed as secondary metabolites during oxidative stress, the aim of this study was to examine the distribution of GSTM1 and GSTT1 polymorphisms in patients with idiopathic infertility.
MATERIAL AND METHODS

Study population
Semen samples were collected from 233 patients (aged 15-69 years) at the Laboratory of Human Reproduction (HC-UFG) in 2004, 2005, and 2006 . The patients were classified according to alterations detected with three consecutive spermograms, based on the WHO technique (1999), in two groups: normozoospermics and those showing alterations (abnormal spermogram). All subjects had a history of infertility with no indication of hormonal, infective, or physical causes for their infertility. The project was approved by the Ethics in Research Committee of the Catholic University of Goiás (#150/2004), and a written informed consent form was signed by all participants.
Molecular analysis
Genomic DNA was extracted from semen with the Illustra TM Blood Genomic DNA kit (GE HealthCare, USA), in accordance with the recommended protocol optimized. The multiplex polymerase chain reaction (PCR) was used for amplification with the specific primer pairs for the genes GSTM1 (215 bp), GSTT1 (480 bp) and RH92600 (135 bp) (Chen et al., 2002) . The PCR products were loaded onto 2% agarose gels for electrophoresis. After electrophoresis, the gels were stained with ethidium bromide and photographed under UV light (Image Master VDS ® -Amersham Pharmacia Biotech, USA) (Figure 1 ). Two bands of 480 bp for GSTT1 and 215 bp for GSTM1 were obtained for the M1/T1 genotype. The M0/T1 genotype showed a band of 480 bp, and the M1/T0 genotype showed a band of 215 bp. For the M0/T0 genotype (homozygous absence or deletion genotype is designated as the null genotype), no bands were obtained and thus the use of an internal positive control (RH92600, 135 bp) was necessary to distinguish the null genotype from aborted PCR. Statistical analysis for the possible associations between molecular analysis and the male idiopathic infertility was compared using the c 2 test. Results were considered to be significant when the probability of findings occurring by chance was less than 5% (P < 0.05). The BioEstat ® 5.0 program (Sociedade Civil Mamirauá/MCT-CNPq) was used to carry out the statistical tests.
RESULTS
Of the 233 samples analyzed, the normal group made up 45.1% (105/233) and the group that showed alterations (abnormal spermogram) 54.9% (128/233), where 29.7% (38) of the latter patients were oligozoospermics, 25% (32) asthenozoospermics, 32.1% (41) teratozoospermics, and 13.2% (17) azoospermics. The mean age of the patients with alterations was 34.66 ± 7.46 (mean ± SD), and for normal individuals this was 33.38 ± 10.01. Homogeneity between the two groups evaluated was established as P = 0.096.
Among the DNA samples analyzed, it was shown that the null genotypic frequency for the two genes GSTM1 and GSTT1 was 28.6% for the normal patients and 50% for the group that showed alterations. Positive genotype for both genes GSTM1 and GSTT1 was 29.5% for the normal patients and 23.4% for the abnormal group, which was found to be significantly different (P = 0.008) ( Table 1) .
GSTM1/GSTT1
Normal Abnormal P Based on the alterations of the spermogram, the null genotype for both genes GSTM1/ T1 was most frequent in oligozoospermics (39.1%), and the positive genotype for both genes was more frequent in asthenozoospermics (36.7%). Isolating the GSTM1 and GSTT1 genes, the null genotype appeared more frequently in oligozoospermic individuals for M1 (78.9%) as well as for T1 (73.7%), while the positive genotype was less frequent in azoospermics for M1 (35.3%) as well as for T1 (47.1%); there was no statistically significant difference (P = 0.350 and P = 0.132, respectively) ( Table 2) . 
DISCUSSION
In homozygosis, individuals with the null allele of the GSTM1 and GSTT1 genes are considered to be a risk group for various diseases, mainly if displaying elevated levels of carcinogens and noxious chemical compounds, because of the enzymatic defect in the detoxification system (Nakata et al., 2004) .
Male infertility has been related to multiple irregularities including sperm concentration, motility and morphology (Huynh et al., 2002) . Recent studies reported a significant decline in human semen quality or deterioration of spermatogenesis over the past decades (Fritsche et al., 1998; Alvarez and Moraes, 2006; Aydemir et al., 2007) . Possible underlying reasons are yet unknown; however, xenobiotics have been suggested to exert adverse effects on the male reproductive system (Pasqualotto et al., 2008) .
Although the influence of age on seminal quality has not yet been well defined, Pasqualotto et al. (2004) reported a decrease in sperm concentration after 45 years of age. Moskovtsev et al. (2006) in a study of 1125 infertile men demonstrated that damage to sperm DNA is significantly greater in men older than 40 years. The mean of age of the patients in our study did not show a significant difference compared to that of controls.
The polymorphism of GSTM1 and GSTT1 genes has been associated with male infertility (Schuppe et al., 2000) and also female infertility (Hadfield et al., 2001; Sata et al., 2003) . When analyzing the genotype frequency within each group of normal and abnormal individuals from the semen sample, a statistically significant association was found between GST polymorphism and idiopathic male infertility. The most frequent genotype was GSTM1/T1 (null) in individuals with an abnormal spermogram, and oligozoospermia was more associated with the null polymorphism of the GSTM1 and GSTT1. Chen et al. (2002) showed a correlation for elevated frequency of GSTM1 (null) and varicocele and subclinical varicocele patients when compared with the fertile group. Similarly, Alkan et al. (1997) indicated a greater predominance of GSTM1 (null) men and infertility; their spermograms pointed to oligozoospermia alone or in combination with asthenozoospermia or teratozoospermia. A possible explanation for sperm reduction in individuals with GSTM1/T1 (null) would be decreased capacity of seminiferous tubules and the increase in fibrosis of the testicular tissue, since the accumulation of xenobiotics not detoxified in the cellular matrix of the testis would impair spermatogenesis (Pajarinen et al., 1996) .
A study in Turkey on infertile individuals according to criteria of the WHO indicated that there was no significant difference in genotypic frequency of GSTM1 (null) between patients of an infertile group (51.9%) and a control group (46.7%) (Aydemir et al., 2007) . However, these authors verified the association between the polymorphism of gene GSTM1 and markers of oxidative stress in patients with idiopathic infertility.
In conclusion, the results of the present study suggest that the decline in the semen quality of individuals with idiopathic infertility is associated with the null genotype of glutathione S-transferase enzymes. Therefore, polymorphism of GSTM1/T1 hampers the important function of these enzymes in the biotransformation of xenobiotics, allowing them to affect the male reproductive system.
